Chemicals / Specialty Chemicals
₹00.121
ALKALI
Alkali Metals Ltd was incorporated on April 17, 1968, making it a well-established chemical manufacturer with over five decades of experience in the industry. The company was initially incorporated as Alkali Metals Private Limited in Hyderabad, Andhra Pradesh, and was later converted into a public limited company on November 6, 2008. Originally established as a joint venture with Andhra Pradesh Industrial Development Corporation Limited (APIDCL), the company has since gained complete operational and management control.
The company is registered at the Registrar of Companies, Hyderabad, and is headquartered at Plot B5, Block III, Uppal Industrial Development Area, Hyderabad, Telangana, India - 500039. Today, Alkali Metals Limited is well recognized as a 'Partner of Choice' by leading global pharmaceutical and life sciences companies.
Alkali Metals Ltd is an ISO 9001 & 14001-certified manufacturer specializing in sodium metal derivatives, picoline-based compounds, and cyclic chemicals. The company manufactures a diverse range of products including Alkali Metal Derivatives, Amino Pyridines, Tetrazoles, Cyclic compounds, and Fine chemicals.
The company's key products include sodium amide, sodium azide, sodium hydride, amino pyridines, fine chemicals, and APIs, primarily supplied to pharmaceutical companies for bulk drug production. Their API products include benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. They also provide pyridine compounds, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic compounds, azaindole, potassium, sodium derivatives, and boronic acids.
The company's products find applications in pharma intermediates, anti-retrovirals, flu vaccines, antibiotics, cardio/anti-inflammation treatments, agrochemicals, and automobile applications. The company operates three manufacturing units located at Uppal, Dommara Pochampally, and JNPC Visakhapatnam.
The company has achieved ISO 14001:2004 and ISO 9001:2000 certifications for its two manufacturing facilities – Unit I and Unit II - with an aggregate production capacity of 4400 MT. The company has received USFDA (United States Food and Drug Administration) approval for its Visakhapatnam Unit in Andhra Pradesh, demonstrating its commitment to maintaining international quality standards.
Alkali Metals evolved as the first company to manufacture sodium metal with in-house R&D capability. The company has its own research and development department along with a research lab equipped with advanced technology and a smart team for synthesis.
The company maintains a strong global presence through its operations in India, USA, Canada, Europe, and Japan, constantly serving customers spread across 10 countries. Alkali Metals is recognized as one of the leading chemical suppliers in India and USA for industrial and specialty chemicals, raw materials, and minerals.
As of July 7, 2025, the market capitalization of Alkali Metals Ltd stands at ₹100.10 Cr. The company reported revenue of ₹82.3 Cr with a net loss of ₹5.80 Cr for FY25. However, the company showed improved performance in Q4 FY25, with net profit rising 676.79% to Rs 4.35 crore in the quarter ended March 2025 as against Rs 0.56 crore during the previous quarter ended March 2024.
- Market Capitalization: ₹100.10 Cr (as of July 7, 2025)
- Promoter Holding: 69.59% (as of March 2025)
- FY2024-25 Performance: Revenue of ₹82.33 Cr, Net Loss of ₹5.80 Cr
- FY2023-24 Performance: Revenue of ₹82.86 Cr, Net Profit of ₹1.13 Cr
- Q4 FY2024-25 Performance: Revenue of ₹24.87 Cr, Net Profit of ₹4.35 Cr
- Q4 FY2023-24 Performance: Revenue of ₹24.42 Cr, Net Profit of ₹0.56 Cr
Mr. Y.S.R. Venkata Rao serves as the Managing Director and is the promoter of the company. A technocrat and second-generation entrepreneur, he holds a B.E. (Mechanical) from Sri Venkateswara University, Andhra Pradesh, and is a Fellow member of the Institution of Engineers (India). He joined the company in 1977 and has been instrumental in steering the company's growth from being a manufacturer of alkali metals to a producer of sodium metal derivatives, cyclic compounds, and fine chemicals.
The Board of Directors, in their meeting held on May 19, 2025, approved the Audited Financials as of March 31, 2025, and recommended a dividend of Rs 0.50 per share. The company has plans to set up a production plant in Pharma City, Visakhapatnam with a capital outlay of 42.72 crores, indicating its commitment to expansion and growth.
Alkali Metals Limited is aimed at extending its operational sphere by exploring global horizons and developing newer products and compositions. The primary motto is to build on competitive science techniques useful for customers. The company's strategic focus is to innovate, collaborate and accelerate the process of delivering products to the market for its customers.
The company continues to strengthen its position in the specialty chemicals sector, leveraging its decades of experience, strong R&D capabilities, and global customer base to drive sustainable growth in the pharmaceutical and chemical industries.